TipRanks
Advertisement
Advertisement

JP:4891 Stock Latest News

TMS Co. Files Phase IIa Trial Plan for Acute Kidney Injury Drug TMS-008
Company AnnouncementsTMS Co. Files Phase IIa Trial Plan for Acute Kidney Injury Drug TMS-008
12d ago
4891
TMS Posts Quarterly Loss, Maintains Strong Equity Base and Suspends Guidance
PremiumCompany Announcements
TMS Posts Quarterly Loss, Maintains Strong Equity Base and Suspends Guidance
5M ago
4891
TMS Enrolls First Japanese Patient in Global Phase II/III Stroke Trial of TMS-007
PremiumCompany Announcements
TMS Enrolls First Japanese Patient in Global Phase II/III Stroke Trial of TMS-007
8M ago
4891
TMS Co., Ltd. Posts Continued Losses but Maintains Strong Equity Base in Shortened Fiscal Year
PremiumCompany Announcements
TMS Co., Ltd. Posts Continued Losses but Maintains Strong Equity Base in Shortened Fiscal Year
8M ago
4891
TMS Posts Loss for Transitional Fiscal Year, Withheld 2026 Guidance Amid Ongoing Uncertainty
PremiumCompany Announcements
TMS Posts Loss for Transitional Fiscal Year, Withheld 2026 Guidance Amid Ongoing Uncertainty
8M ago
4891
TMS Co., Ltd. Reports Financial Losses for Six Months Ending August 2025
PremiumCompany AnnouncementsTMS Co., Ltd. Reports Financial Losses for Six Months Ending August 2025
12M ago
4891
TMS Co., Ltd. Reports Q1 Losses Amidst Improved Financial Position
Premium
Company Announcements
TMS Co., Ltd. Reports Q1 Losses Amidst Improved Financial Position
1y ago
4891
TMS Co., Ltd. Advances Global Clinical Trial for Stroke Treatment
Premium
Company Announcements
TMS Co., Ltd. Advances Global Clinical Trial for Stroke Treatment
1y ago
4891
TMS Co., Ltd. Advances Stroke Treatment Study with PMDA Submission
PremiumCompany Announcements
TMS Co., Ltd. Advances Stroke Treatment Study with PMDA Submission
1y ago
4891
TMS Co., Ltd. Reports Reduced Losses in Fiscal Year 2025
PremiumCompany Announcements
TMS Co., Ltd. Reports Reduced Losses in Fiscal Year 2025
2y ago
4891
TMS Co., Ltd. Reports Positive Phase I Results for TMS-008
PremiumCompany Announcements
TMS Co., Ltd. Reports Positive Phase I Results for TMS-008
2y ago
4891
TMS Co., Ltd. Announces Royalty Payment from CORXEL Dividend
PremiumCompany Announcements
TMS Co., Ltd. Announces Royalty Payment from CORXEL Dividend
2y ago
4891
TMS Co., Ltd. Aligns Fiscal Year with Global Standards
PremiumCompany AnnouncementsTMS Co., Ltd. Aligns Fiscal Year with Global Standards
2y ago
4891
TMS Co., Ltd. Partners with Tokushima University for Joint Research
Premium
Company Announcements
TMS Co., Ltd. Partners with Tokushima University for Joint Research
2y ago
4891
TMS Co., Ltd. Advances Stroke Treatment with New Global Trial Approval
Premium
Company Announcements
TMS Co., Ltd. Advances Stroke Treatment with New Global Trial Approval
2y ago
4891
TMS Co., Ltd. Presents Promising Stroke Treatment at ISC 2025
PremiumCompany Announcements
TMS Co., Ltd. Presents Promising Stroke Treatment at ISC 2025
2y ago
4891
TMS Co., Ltd. Reports Nine-Month Financial Results with Net Loss
PremiumCompany Announcements
TMS Co., Ltd. Reports Nine-Month Financial Results with Net Loss
2y ago
4891
TMS Co., Ltd. to Lead Executive Roundtable at WuXi Global Forum 2025
PremiumCompany Announcements
TMS Co., Ltd. to Lead Executive Roundtable at WuXi Global Forum 2025
2y ago
4891
TMS Co., Ltd. Highlights 2024 Achievements and 2025 Goals in Shareholder Letter
PremiumCompany Announcements
TMS Co., Ltd. Highlights 2024 Achievements and 2025 Goals in Shareholder Letter
2y ago
4891
TMS Co., Ltd. to Join J.P. Morgan Healthcare Event
PremiumCompany AnnouncementsTMS Co., Ltd. to Join J.P. Morgan Healthcare Event
2y ago
4891
TMS Co., Ltd. Highlights Promising Stroke Treatment
Premium
Company Announcements
TMS Co., Ltd. Highlights Promising Stroke Treatment
2y ago
4891
TMS Co., Ltd. Gains U.S. Patent for Kidney Treatment
Premium
Company Announcements
TMS Co., Ltd. Gains U.S. Patent for Kidney Treatment
2y ago
4891

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >